Skip to content

Lentinan Exerts Antitumor Activity in Non-small Cell Lung Cancer through P53-mediated Cytochrome c Release and Caspase Activation: A Preclinical Study.

Aug 2026 · Current Medicinal Chemistry · Vol 33 · 0 citations
Medicine

TL;DR

These in vivo experiments further demonstrated that LTN exhibits a significant inhibitory effect on tumor growth in a lung cancer model, indicating that LTN, as a natural compound, exhibits the potential for multi-target action in the treatment of NSCLC.

Abstract

INTRODUCTION Lentinula edodes is regarded as a functional food and dietary supplement due to its significant nutritional and medicinal value. Lentinan (LTN) was reported to enhance immune function and exhibit antitumor activity. Although numerous studies have confirmed the inhibitory effect of LTN on tumors in vitro, its underlying mechanisms remain unclear.

Methods

The present study was designed to investigate the anticancer effects of LTN and the associated mechanisms in a non-small cell lung cancer (NSCLC) cell model.

Results

Lentinan has been demonstrated to exert anti-proliferative effects on NSCLC cells. Furthermore, studies indicate that it effectively induces cell cycle arrest, promotes apoptosis, and suppresses the migration and invasion capabilities of NSCLC cells. Mechanistically, LTN has been observed to upregulate the expression of P53-related proteins and downregulate matrix metalloproteinases (MMPs). These findings strongly suggest that LTN induces apoptosis in NSCLC cells through caspase activation mediated by mitochondrial cytochrome c release. We also employed Magnetic Resonance Imaging (MRI) to monitor tumor growth in mice, with results demonstrating a significant reduction in tumor size in the treatment group. Additionally, Laser Speckle Contrast Imaging was utilized to assess blood perfusion in the axillary region of these mice.

Discussion

This study indicates that LTN, as a natural compound, exhibits the potential for multi-target action in the treatment of NSCLC. By inducing the mitochondrial apoptosis pathway and modulating tumor cell behavior, LTN demonstrates significant antitumor effects. These findings provide a solid experimental foundation for the further clinical development of LTN.

Conclusion

These in vivo experiments further demonstrated that LTN exhibits a significant inhibitory effect on tumor growth in a lung cancer model.

View source

Similar papers

Open access Sep 2026

Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling

Background and Objectives: Drug repurposing provides an opportunity to identify anticancer activities among established pharmacological agents. Labetalol (LB), an α1- and non-selective β-adrenergic receptor antagonist, has been insufficiently investigated in melanoma. This study evaluated the potential anti-melanoma ac...

Richard Dahma, E. Moacă, I. Predescu et al. · 0 citations
Open access Sep 2026

Saikosaponin A Induces Apoptosis in HCT116 Colorectal Cancer Cells via ROS-Mediated ER Stress and p38/JNK MAPK Pathway Activation: in Vitro and in Vivo Evidence

Colorectal cancer (CRC) is the third most prevalent cancer globally, with limited effective treatment options and significant chemotherapy resistance. Saikosaponin A (SSA), a triterpenoid saponin from Radix Bupleuri, exhibits anti-inflammatory and antitumor properties, but its mechanism of action in CRC remains und...

Xiu-Xiu Zhang, Jing-Ling Yang, Wang-Wei Zhang et al. · 0 citations
Open access Sep 2026

Hesperidin Enhances the Antitumor Effect of Gefitinib Against Non-Small Cell Lung Cancer via Activation of Endoplasmic Reticulum Stress

Background: This study was designed to evaluate whether hesperidin (HES) could enhance the antitumor activity of gefitinib (GEF) against A549 non-small cell lung cancer (NSCLC) cells. Moreover, the molecular basis of this activity was also investigated using both in vitro and in vivo approaches. Methods: The viability...

Juan Pan, You-Jing Wang, Ting-Ting Li et al. · 0 citations
Open access

Molecular functional evaluation of novel c-myc targeting anticancer compounds in non-small cell lung cancer and colon cancer cells

The c-Myc protein is a key regulator of cell growth, proliferation, and differentiation. Its overexpression or dysregulation is linked to several cancers, including non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). Here, we described ECD, a novel small molecule targeting c-Myc, which disrupts the c-Myc/MA...

Nicharat Sriratanasak · 0 citations
Open access Sep 2026

Targeting Iron Regulatory Protein 2 in Tumor-associated Macrophages Activates Antitumor Immunity in NSCLC via Modulating SphK1-PD-L1 Axis

IRP2-dependent maintenance of the immunosuppressive TAM phenotype as a promising therapeutic target in NSCLC is identified, finding that IRP2 skewed TAMs toward an immunosuppressive state that promoted tumor cell proliferation and migration, and limited apoptosis.

Jia-Wen Ding, Qin-Pei Cheng, Chen Cheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.